Page 28 - Read Online
P. 28

Nappi et al. Vessel Plus 2021;5:40  https://dx.doi.org/10.20517/2574-1209.2021.06  Page 19 of 20

                   experience. Interact Cardiovasc Thorac Surg 2012;14:575-9.  DOI  PubMed  PMC
               6.       Bourguignon T, Bouquiaux-Stablo AL, Loardi C, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards
                   pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg 2014;148:2004-11.e1.  DOI  PubMed
               7.       Condado JF, Kaebnick B, Babaliaros V. Transcatheter mitral valve-in-valve therapy. Interv Cardiol Clin 2016;5:117-23.  DOI
                   PubMed
               8.       Nappi F, Avtaar Singh SS, Padala M, et al. The choice of treatment in ischemic mitral regurgitation with reduced left ventricular
                   function. Ann Thorac Surg 2019;108:1901-12.  DOI  PubMed  PMC
               9.       Nappi F, Lusini M, Avtaar Singh SS, Santana O, Chello M, Mihos CG. Risk of ischemic mitral regurgitation recurrence after
                   combined valvular and subvalvular repair. Ann Thorac Surg 2019;108:536-43.  DOI  PubMed
               10.      Elmariah S, Arzamendi D, Llanos A, et al. First experience with transcatheter valve-in-valve implantation for a stenotic mitral
                   prosthesis within the United States. JACC Cardiovasc Interv 2012;5:e13-4.  DOI  PubMed
               11.      Coylewright M, Cabalka AK, Malouf JA, et al. Percutaneous mitral valve replacement using a transvenous, transseptal approach:
                   transvenous mitral valve replacement. JACC Cardiovasc Interv 2015;8:850-7.  DOI  PubMed
               12.      Nappi F, Spadaccio C, Sablayrolles JL. Pushing the limits in transcatheter aortic valve replacement: High-volume center's effect,
                   overconfidence, or something else? JACC Cardiovasc Interv 2016;9:2186-8.  DOI  PubMed
               13.      Sorajja P, Mack M, Vemulapalli S, et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am
                   Coll Cardiol 2016;67:1129-40.  DOI  PubMed
               14.      Eleid MF, Cabalka AK, Williams MR, et al. Percutaneous transvenous transseptal transcatheter valve implantation in failed
                   bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv 2016;9:1161-74.  DOI
                   PubMed
               15.      Eleid MF, Whisenant BK, Cabalka AK, et al. Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation
                   in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv 2017;10:1932-
                   42.  DOI  PubMed
               16.      Attias D, Nejjari M, Nappi F, Dreyfus J, Eleid MF, Rihal CS. How to treat severe symptomatic structural valve deterioration of aortic
                   surgical bioprosthesis: transcatheter valve-in-valve implantation or redo valve surgery? Eur J Cardiothorac Surg 2018;54:977-85.
                   DOI  PubMed
               17.      Rumsfeld JS, Holmes DR Jr, Stough WG, Edwards FH, Jacques LB, Mack MJ. Insights from the early experience of the Society of
                   Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. JACC Cardiovasc Interv 2015;8:377-81.
                   DOI  PubMed
               18.      Carroll JD, Edwards FH, Marinac-Dabic D, et al. The STS-ACC transcatheter valve therapy national registry: a new partnership and
                   infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol 2013;62:1026-34.  DOI
                   PubMed
               19.      Feldman T, Kar S, Elmariah S, et al; EVEREST II Investigators. Randomized comparison of percutaneous repair and surgery for
                   mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 2015;66:2844-54.  DOI  PubMed
               20.      Ghoreishi M, Dawood M, Hobbs G, et al. Repeat sternotomy: no longer a risk factor in mitral valve surgical procedures. Ann Thorac
                   Surg 2013;96:1358-65.  DOI  PubMed
               21.      Patel NC, Hemli JM, Seetharam K, et al. Reoperative mitral valve surgery via sternotomy or right thoracotomy: A propensity-matched
                   analysis. J Card Surg 2019;34:976-82.  DOI  PubMed
               22.      Suri RM, Schaff HV, Dearani JA, et al. Recurrent mitral regurgitation after repair: should the mitral valve be re-repaired? J Thorac
                   Cardiovasc Surg 2006;132:1390-7.  DOI  PubMed
               23.      Hu J, Chen Y, Cheng S, et al. Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical
                   annuloplasty rings: A systematic review and meta-analysis. J Card Surg 2018;33:508-19.  DOI  PubMed  PMC
               24.      Yoon SH, Whisenant BK, Bleiziffer S, et al. Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed
                   annuloplasty rings. J Am Coll Cardiol 2017;70:1121-31.  DOI  PubMed
               25.      Nishida H, Fukui T, Kasegawa H, Kin H, Yamazaki M, Takanashi S. Causes of repair failure for degenerative mitral valve disease and
                   reoperation outcomes. Eur J Cardiothorac Surg 2018;53:1244-50.  DOI  PubMed
               26.      Grover  FL,  Vemulapalli  S,  Carroll  JD,  et  al;  STS/ACC  TVT  Registry.  2016  Annual  Report  of  The  Society  of  Thoracic
                   Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. J Am Coll Cardiol 2017;69:1215-30.  DOI  PubMed
               27.      Stone GW, Lindenfeld J, Abraham WT, et al; COAPT Investigators. Transcatheter mitral-valve repair in patients with heart failure. N
                   Engl J Med 2018;379:2307-18.  DOI  PubMed
               28.      Obadia JF, Messika-Zeitoun D, Leurent G, et al; MITRA-FR Investigators. Percutaneous repair or medical treatment for secondary
                   mitral regurgitation. N Engl J Med 2018;379:2297-306.  DOI  PubMed
               29.      Nappi F. The use of subvalvular repair for functional mitral regurgitation. Ann Thorac Cardiovasc Surg 2020.  DOI  PubMed
               30.      Nappi F, Avatar Singh SS, Santana O, Mihos CG. Functional mitral regurgitation: an overview for surgical management framework. J
                   Thorac Dis 2018;10:4540-55.  DOI  PubMed  PMC
               31.      Cheung A, Webb JG, Barbanti M, et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for
                   bioprosthetic valve dysfunction. J Am Coll Cardiol 2013;61:1759-66.  DOI  PubMed
               32.      Nappi F, Spadaccio C, Chello M, Lusini M, Acar C. Double row of overlapping sutures for downsizing annuloplasty decreases the risk
                   of residual regurgitation in ischaemic mitral valve repair. Eur J Cardiothorac Surg 2016;49:1182-7.  DOI  PubMed
               33.      Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation
                   2010;121:1848-57.  DOI  PubMed
   23   24   25   26   27   28   29   30   31   32   33